Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Will the convertible be one of those 'Jetson' style floating convertibles?
"Since its founding more thirty years ago, Baxa Corporation has set aside money and resources for giving back to the community."
Wow, it sounds like they have cash reserves! Has Baxa exercised their stock option and invested further into CDEx and their revolutionary Valimed system which utilizes patented technology licensed from Analytical Spectral Devices, Inc.?
Will they put cash into CDEx to save Valimed? I see no reason why they wouldn't. Except for one.
After all the hype about revolutionary technology, after MP's spectacular finacial prospectus projecting 10 million+ in revenues in a few short years, after over 23 million dollars spent with insiders lining their pockets... no wonder the PP investors said "No" and left the company "twisting in the wind".
They must be a p'ed off group of investors.
And just like every product before it, the meth gun is being hyped ad nauseum by the paid stock promoters, but guess what?
Even if the product works to a useful degree you won't see any significant sales for a long time, at least nothing that will save the company.
Remember how Valimed was hyped endlessly on the boards and look how it's selling now. I believe the meth gun will turn out exactly the same, especially since the market already has lots of competition unlike the launch of Valimed.
Face the truth, the only thing that has ever has kept this company afloat (for 20 years) is selling stock and the situation has not changed, even with the revolutionary Valimed.
Sanddollar as a formidable vocabulary.
Paige, get over here right now. I forbid you to make such an absurd statement like that.
I know you have a good imagination, but that's stretching it a bit.
I won't put a statement like that past doyourdd, but not Paige!! LOL
It would appear that some type of financing has definately (TM- Close/upandin0) occurred
Paige,
Is this your post? I thought you were a little bit more intelligent than that. I really did.
"Ahhh I thought that they "dropped" the infringment suit. We didn't infringe and they had a valid patent remember?"
And by acknowledging the validity of ASD's patent what does CDEX have to do in order to continue manufacturing Valimed?
YES, pay royalty fees. If they weren't infringing why would they do that! LOL
Geesh!!!
You're right Crow, the Ask couldn't hold with the sell-off volume. News must be right around the corner.
I can hardly believe that CDEX has a solid lead in Japan if they can't fork out 5K to get someone over there to close a deal:
The Japanese pharmaceutical market is the second largest individual market and with sales of $60 billion constitutes approximately 11% of the world market.
http://www.leaddiscovery.co.uk/reports/Japanese_Pharmaceutical_Market.html
A "visit" means very little if you are familiar with doing business with Japan. The Japanese are notorius for wanting to visit a company's facility if they have an interest in their product or service. A visit is not so much an indication that they want to do business with you as it is they want to learn as much as they can about your business.
Our company was under a six figure (500K+) service contract with Nintendo of America to perform repairs which they did not have the capability to do. Our service was saving them millions $. During the course of the contract we received a call that a group of Japanese engineers wanted to visit our repair facility to observe our process. We flatly refused and said if they showed up we'd shut down the operation for the day.
How does this related to CDEX? A visit by a Japanese company don't mean sheet and most likely is not in your best interests.
Make that over 15 concept products if you include the SafePill 1, SafePill 2... Safe Pill 5 etc.
LOL Unbelieveable people can be so gullible.
Over and over and over again.
"Seeking CDEX contact for PS3"
The PS3 is a concept product which never made it into production beyond a jury-rigged prototype and a mock-up picture used to sell shares in the penny stock.
It sits with at least 10 other BS products Loch/CDEX have "marketed" over the years.
Why does upandin0 continue to think MP and the "clan" are bleeding shares into the market and at the same time think so postively about the future of CDEx?
Seems like a contradiction. Why would MP sell with upandin0 so postive about the future? LOL
California has always lead the "meth crisis" and I agree with you, if the meth gun proves useful to supplement canines, it is reasonable to assume that California will be a customer.
"I fully expect a bunch of small time wiz bangs to tear this apart, but time will tell who is right or wrong."
High C, is "small time wiz bangs" considered name calling? LOL
Actually, there's really nothing to tear apart, your speculation is as good or bad as anyone elses.
"Wiz bang", that's funny! LOL
Still no volume. Can't dump and no one buying. Everyone just waiting for the announcement of funding which has to be the number one priority.
On another subject (back to foreign distributors), I wonder how the laws which regulate pharmacies in other countries parallel our own.
Are they conducive to Valimed sales or are they lagging behind the USA?
Cappy, have you any info on that subject? How about Japan?
Which means they're more interested in selling shares than Valimed's?
"In the short term"
- MP
LOL!! I actually meant Missouri, not Kansas. Although Kansas is in a very similar strategic location as Missouri- the cross roads of the nation.
I have to strongly agree with Bulldogconslt. If CDEX has a chance to set up a distributor in Japan they should get out the credit card and go!
It is typical to include a very nice initial sale when setting up a foreign distributor. I can easily see CDEX shipping 10-15 units.
What is disturbing is the 38% discount they're offering here. That would normally be about the discount rate for a foreign distributor. If continued, that could be damaging to the price structure.
I can only assume that the lead is not promising enough to use a credit card, which BTW, has an interest rate well below that given to the lucky PP investor that raked in 33%. I wonder who that was. Kitty was that you again?
I wonder which agency is funding the Kansas Highway Patrol to field test the meth gun. Griffin stated several times (with emphasis) that the test is funded. I suspect that the department picks up a good chunk of change for conducting various tests.
I spoke with a spectroscopist at Ahura (they want to let me use a FirstDefender free for a month) and he said that several companies which he has been associated with have gone through field testing with the KSHP.
He had some very interesting comments about dealing with them during field testing.
"But most people grasp the wire harder..which is why they get killed."
In many cases, the muscles in your hand contract from the voltage which doesn't allow you to let go. That's why professionals working around high voltage condition themselves to pull away forcefully and immediately when shocked.
If you see someone being electrocuted don't grab their arms or other part of their body in an attempt to yank them loose. You could be electrocuted too. Instead, try to knock their arm away from the voltage source to break their grip. Use your arm or other object as a club, don't grab with your hands.
A month ago Closer wasn't sure if CDEX had the tech, but now after learning that CDEX admits that Valimed infringed on ASD's patent Closer "knows" CDEx has the tech! LOL
As I've asked for several years, what's revolutionary? We NOW know it's not the Valimed which is nothing more than a dedicated fluorimeter designed for a niche market IMO. So what's left?
Ahhh yes the meth gun! Trace detection in open air!
Maybe this new crisis market will accept a small scan footprint at under an inch stand-off distance- something that the Army and Navy both declined. "Under an inch" is what CDEX stated in the DOJ report.
I will be very interesting to see how well the meth gun performs.
I don't know about Crow, but the needle on my BS meter starts quivering whenever the message board stock promoters post their advertisments.
Sorry Mr. Griffin...
"... in my opinion it's not enough just to sell the meth gun as an end, as a be all and end all device. It's what a lot of companies do, they just go out and sell a device."
Not the companies which have won numerous awards for chemical detection excellence like Ahura and Smith (both which have been reviewed on this board). They have an upgradeable signature capability by wireless download.
In other words, Loch/CDEX is once again playing catch-up with companies that don't talk about it, they've already done it.
Thanks for bringing that up Cappy, I had wanted to comment on that earlier.
... and maybe, just maybe ASD plans on coming out with a smaller "hospital pharmacy" version of their technology for solids.
After all, "there are lot's of hospitals".
INET, it WAS the exact same UVF technology in a different "box" as stated by MP and Griffin many times- "the same photo-electric technology is the platform for all the companies products... etc." (paraphrased)
"Like I say if they could sell Valimed in a suitcase why would they be able to demand 10,20,or30, or whatever thousands.
Get Real ValiMeds 20x10x7 guts would not fit in what I saw.
Enough of your Bhsh4t I;ve got better things to do."
That means absolutely nothing INET. You don't seem to have too much knowledge about marketing.
I'd be willing to bet that the Valimed enclosure is half empty. How do you suppose they can take the exact same technology and put it in a hairdryer size enclosure that allegedly tests solids. Hmmm... just like that little meth gun is suppose to do... and didn't they say it would eventually be even smaller?
Packaging is part of the marketing game.
Valimed is a lab top instrument for hospitals. It is not designed to be portable. It has a large display for ease of use and the target market is high-end.
I've watched one company sell a product for top dollar very successfully. When the competition came in low-balling their price the company came out with a dirt cheap product to compete with the low-ballers. They marketed the low cost version under a different name and were able to not only dominate the high-end market, but take a considerable portion of the low-end market as well.
Now here's the rub, the high-end product and low-end product were the exact same thing packaged slightly different with different brand names. They were also made in the very same factory, the same resources, the same quality.
If they dropped the price of a bottle of Dom Perignon Champagne by 50% do you think sales would increase or decrease?
No Crow I do not. I believe it was a prototype pill checker for counterfeits that proven to not work so well for solid dosage forms (as evident from INET's testimony) I get the same impression as you that it was the Valimed "works" in a different (portable) box.
So why have they stopped development of the counterfeit drug detector, money or ASD will not grant them a license for solids?
So why have they stopped development of the trace explosive detector, money or the damn thing would never work like the scamsters originally advertsied?
"His assistant(I can't recall his name,a black man,nice gentleman)activated it and got a "not validated' reading, Griffin shook it up, and then they got a validated reading."
Evidently Griffin knew it was suppose to be real Tamiflu. He knew he had to "shake it up" and test it a second time to get a "validated" test result.
Sounds like the test took a little "operator interpretation"! LOL!
FDA approved Tamiflu (oseltamivir phosphate), an oral anti-viral drug for the treatment of uncomplicated influenza in patients one year and older whose flu symptoms have not lasted more than two days.
http://www.fda.gov/cder/drug/infopage/tamiflu/default.htm
High C, I don't think a poster can send personal emails if they are a free (non-paying) account.
However, if someone replies to your post it will automatically go to your mailbox if you don't read it- that feature is a freebie.
Maybe that don't have the money to pay the message board penny stock promoters anymore.
"This is very pleasing" LOL!!!!!
Xeno, is it true that Pigs is going to ask his "journalist friend" to feature you and I in an article?
Why do they think that we work for The Other Company? LOL
Hmmm... the MM's decided not to close out the day at .41
All eyes should be on Upandin0's posts. It appears he's hearing that "chatter" once again or remembers how the game has been played in the past:
"ALL I know is that IF there are willing CDEX SELLERS, knowing what I know, I'm a willing BUYER of Cexi'CDEX! GLTU!!!
"...I'd like some CLARITY as to the exact payout to ASD, but IMHO, "that's" not what is keeping the PPS @ a 1 CENT LOCH. I believe it's MEGA shareholder's (the Booney's, the Bakerboy's, some rotten lawyer's, and the Phillip's clan) willing to dump shares on any good news."
"...FWIW, keep WATCHING THE VOLUME because some INSIDERS will LIKELY start BUYING when the TIMING is PERFECT. GLTU!!!"
"...hey folks, have a GAME PLAN, WATCH THE VOLUME, and don't let anyone STEAL your shares, ESPECIALLY NOW!!!"
"...the lack of FOLLOW THROUGH on PPS is due to CDEX shareholder's (I believe insider's who know THE TIMETABLE) willing to SELL and/or MM's who will take an 8-10 CENT gain"
Looks like Milchip got it right.
Xeno,
Has CDEX cited ASD and other references (such as the ones you have posted) in their currently pending patent applications which seem to be more specifically targeted toward pharmaceutical validation?
Note the date on this PR, three days prior to the law suit announcement:
Seventh US Patent Issued to Analytical Spectral Devices, Inc. Related to Verification of Pharmaceuticals
Boulder, Colo., March 10, 2006 — Analytical Spectral Devices, Inc. (ASD), manufacturer of precision analytical instruments for real-time, field based material identification and verification, announced today that the United States Patent and Trademark Office has issued Patent Number 7,006,214 related to ASD’s innovative solution, RxSpec® technology. “This is ASD’s seventh patent covering pharmaceutical verification and the second patent specifically related to our RxSpec® drug verification solution” says Dave Rzasa, President and CEO. “These patents further strengthen ASD’s leadership position in providing solutions to furthering pharmacist productivity, while at the same time combating counterfeits.”
ASD’s patented RxSpec® technology utilizes a combined visible and near infrared spectroscopy inspection system to directly check the prescription drug while in the dispensing vial. The real-time measurement is sensitive to chemical composition, color, and dosage level. The measured “chemical fingerprint” is compared to an extensive known database, thereby providing absolute assurance that the dispensed drug is correct in both type and concentration, regardless of similarity in appearance. In seconds, RxSpec® technology verifies the identity and dosage of a prescription drug dispensed by a pharmacy, thereby reducing potentially harmful filling errors, as well as detecting counterfeit drugs. And because RxSpec® technology is non-destructive, it can be used to inspect 100% of the prescriptions prepared by a pharmacy.
ASD currently has systems installed at two large central fill and mail order pharmacies which have verified several million filled prescriptions very successfully. With the systems currently in operation, combined with the installations at the two new Department of Veteran’s Affairs Consolidated Mail Outpatient Pharmacies in Chelmsford, Massachusetts and Tucson, Arizona, ASD will continue to grow an already extensive library of unique spectral fingerprints of the most commonly dispensed prescription drugs.
“RxSpec® technology is the first real tool to automate the time consuming and labor intensive manual verification process used in virtually every pharmacy. The technology is applicable in all pharmacy environments, including central fill, mail order, retail, and hospital pharmacies,” says Dr. Brian Curtiss, Chief Technology Officer. “While ASD’s current systems have focused on verification of solid dosage pharmaceuticals in high volume pharmacies, ASD has versions of the RxSpec® system in development for a wide range of additional dosage forms, including injectables and IV solutions.”
And CDEX new about this all along? I can only imagine how angry some of the PP investors must be thinking that they had invested in a revolutionary technology.
Paige, why do you ask me a question which you can readily look up yourself. Even doyourdd can find the answer.
http://www.asdi.com/news-pr.asp
At what time? eom
INET, do you miss that little "igit head" Kidinsight that use to be so entertaining with his posts?
Kidinsider logically explaining why the ASD tech doesn't work:
(Of course, based on his extensive reading and DD on the subject matter! LOL)
By: kidinsight
20 Jan 2005, 01:39 AM EST
Msg. 229663 of 239484
This msg. is a reply to 229639 by diddy.)
diddy:
IMHO, based on the reading and DD I have done with some of these companies you have talked about, I cannot help but wonder why any company would choose the VIS/IR spectrum. It sounds to me, the IR has got some unsolved problems that could adversely affect measurements.
Do you agree or disagree with my logic?
tia
I direct our on-line, penny stock promoters/researchers to this website. Maybe they can find another concept product for launch after the meth gun hype fizzles out. Gotta keep lining up those carrots well in advanced dontchaknow:
http://www.military-medical-technology.com/